Delpor, Inc.
Pharmaceutical company · San Francisco, California, United States
Delpor, Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2009. It has received 8 US government small-business research awards (SBIR/STTR) from health agencies, $14 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $470,000 sold in a notice filed in 2013.
Delpor at a glance
What does Delpor do?
US government research funding
8 SBIR/STTR small-business research awards from US health agencies, $14.1 million in total (2012 to 2021). NIH funding came from the National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $470,000 sold (2013).
Frequently asked questions about Delpor
Where is Delpor headquartered?
Delpor, Inc. is headquartered in San Francisco, California, United States.
What does Delpor do?
Delpor, Inc. is a pharmaceutical company.
When was Delpor founded?
The earliest incorporation on record for Delpor, Inc. is in 2009, according to public company registers.
Similar companies
- Kyntra Bio, Inc.San Francisco, California, United States
- Nektar TherapeuticsSan Francisco, California, United States
- Olema Pharmaceuticals, Inc.San Francisco, California, United States
- GT Biopharma, Inc.San Francisco, California, United States
- Jaguar Health, Inc.San Francisco, California, United States
- Silver Creek Pharmaceuticals, Inc.San Francisco, California, United States
- Amarantus Bioscience Holdings, Inc.San Francisco, California, United States
- Napo Pharmaceuticals IncSan Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences